Asphalathi linearis herba

Authors: Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

Our authors

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Massaitee; Rooibos tea; Rooibos Tea

Definition
This section has been translated automatically.

Asphalathi linearis herba, also known as rooibos tea, massai tea or rooibos tea, is a frequently used tea variety, which is also used medicinally and therefore belongs to the herbal drugs.

Ingredients
This section has been translated automatically.

Asphalathi linearis herba contains the minerals copper and fluoride, 4 to 5% hydrolysable tannins (gallotannins) and the following flavonoids: luteolin, quercitin, quercetin, rutoside, isoquercitin, vextin, asphalathin (unfermented 3 to 12%) and nothofagin (unfermented up to 1.2%).

Effects
This section has been translated automatically.

Rooibos tea has anti-inflammatory, antioxidant, anti-allergenic, antimutagenic and anti-carcinogenic properties. In addition, it lowers LDL and triglyceride levels and thus has a preventive effect against arteriosclerosis.

Field of application/use
This section has been translated automatically.

Asphalathi linearis herba is used for external application in cosmetic products or for diaper dermatitis. For internal use in gastrointestinal tract complaints, to increase general well-being, for the prophylaxis of arteriosclerosis and as a drink during sports.

Dosage
This section has been translated automatically.

It is advisable to take a cup of tea several times a day at about 2.5 g per cup.

Undesirable effects
This section has been translated automatically.

There are no known adverse effects.

Contraindication
This section has been translated automatically.

There are no known contraindications.

Interactions
This section has been translated automatically.

There are no known interactions with other drugs.

Literature
This section has been translated automatically.

  1. Schilcher H (2016) In: Guide to Phytotherapy, Urban & Fischer Verlag Munich, p. 271 f.